Authors:
SOWADE B
SOWADE O
MOCKS J
FRANKE W
WARNKE H
Citation: B. Sowade et al., THE SAFETY OF TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN CLINICAL USE - A REVIEW OF CONTROLLED-STUDIES, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1(2), 1998, pp. 303-314
Authors:
RAU B
SCHLAG PM
WILLEKE F
HERFARTH C
STEPHAN P
FRANKE W
Citation: B. Rau et al., INCREASED AUTOLOGOUS BLOOD DONATION IN RECTAL-CANCER BY RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHEPO), European journal of cancer, 34(7), 1998, pp. 992-998
Authors:
SOWADE O
MESSINGER D
FRANKE W
SOWADE B
SCIGALLA P
WARNKE H
Citation: O. Sowade et al., THE ESTIMATION OF EFFICACY OF ORAL IRON SUPPLEMENTATION DURING TREATMENT WITH EPOETIN-BETA (RECOMBINANT-HUMAN-ERYTHROPOIETIN) IN PATIENTS UNDERGOING CARDIAC-SURGERY, European journal of haematology, 60(4), 1998, pp. 252-259
Citation: W. Franke et al., PLANTAR MALIGNANT-MELANOMA - A CHALLENGE FOR EARLY DETECTION, Journal of investigative dermatology, 110(4), 1998, pp. 712-712
Citation: W. Franke, PSYCHOANALYSIS AS A HERMENEUTICS OF THE SUBJECT - FREUD, RICOEUR, LACAN, Dialogue. Canadian Philosophical Association, 37(1), 1998, pp. 65-81
Authors:
SOWADE O
SOWADE B
GROSS J
BRILLA K
ZIEMER S
FRANKE W
STEPHAN P
SCIGALLA P
WARNKE H
Citation: O. Sowade et al., EVALUATION OF ERYTHROPOIETIC ACTIVITY ON THE BASIS OF THE RED-CELL AND RETICULOCYTE DISTRIBUTION WIDTHS DURING EPOETIN-BETA THERAPY IN PATIENTS UNDERGOING CARDIAC-SURGERY, Acta haematologica, 99(1), 1998, pp. 1-7
Citation: W. Franke et A. Scherhag, TOLERABILITY AND EFFICACY OF MULTIDOSE FORMULATIONS OF EPOETIN-BETA, Clinical drug investigation, 13(4), 1997, pp. 199-206
Authors:
MOCKS J
FRANKE W
EHMER B
QUARDER O
SCIGALLA P
Citation: J. Mocks et al., CLINICAL SAFETY PROFILE OF LONG-TERM EPOETIN BETA-TREATMENT IN 3697 PATIENTS OF 22 CLINICAL-TRIALS, Journal of the American Society of Nephrology, 8, 1997, pp. 1026-1026
Authors:
MOCKS J
FRANKE W
EHMER B
QUARDER O
SCIGALLA P
Citation: J. Mocks et al., EPOETIN REDUCES MORTALITY - CLINICAL-TRIALS IN 3111 HD PATIENTS SHOW A DECREASED CV RISK, Journal of the American Society of Nephrology, 8, 1997, pp. 1027-1027
Authors:
SOWADE O
SOWADE B
BRILLA K
FRANKE W
STEPHAN P
GROSS J
SCIGALLA P
WARNKE H
Citation: O. Sowade et al., KINETICS OF RETICULOCYTE MATURITY FRACTIONS AND INDEXES AND IRON STATUS DURING THERAPY WITH EPOETIN-BETA (RECOMBINANT-HUMAN-ERYTHROPOIETIN)IN CARDIAC-SURGERY PATIENTS, American journal of hematology, 55(2), 1997, pp. 89-96
Authors:
ZIEMER S
SOWADE O
SOWADE B
FRANKE W
STEPHAN P
REICHE J
GLATZEL E
SCIGALLA P
WAMKE H
Citation: S. Ziemer et al., MARKERS OF COAGULATION FIBRINOLYSIS ACTIVATION, AND WHOLE-BLOOD VISCOSITY (WBV) IN PATIENTS UNDERGOING CARDIAC-SURGERY TREATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHEPO)/, Thrombosis and haemostasis, 1997, pp. 2142-2142
Authors:
SOWADE O
ZIEMER S
SOWADE B
FRANKE W
MESSINGER D
ZIEBELL E
SCIGALLA P
WARNKE H
Citation: O. Sowade et al., THE EFFECT OF PREOPERATIVE RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY ON PLATELETS AND HEMOSTASIS IN PATIENTS UNDERGOING CARDIAC-SURGERY, The Journal of laboratory and clinical medicine, 129(3), 1997, pp. 376-383
Authors:
SOWADE O
GROSS J
SOWADE B
WARNKE H
FRANKE W
MESSINGER D
SCIGALLA P
LUN A
GLATZEL E
Citation: O. Sowade et al., EVALUATION OF OXYGEN AVAILABILITY WITH OXYGEN STATUS ALGORITHM IN PATIENTS UNDERGOING OPEN-HEART-SURGERY TREATED WITH EPOETIN-BETA, The Journal of laboratory and clinical medicine, 129(1), 1997, pp. 97-105
Citation: Ja. Tait et al., GEODYNAMIC EVOLUTION OF THE EUROPEAN VARISCAN FOLD BELT - PALEOMAGNETIC AND GEOLOGICAL CONSTRAINTS, Geologische Rundschau, 86(3), 1997, pp. 585-598
Authors:
SCHAFER J
NEUROTH H
AHRENDT H
DORR W
FRANKE W
Citation: J. Schafer et al., ACCRETION AND EXHUMATION AT A VARISCAN ACTIVE MARGIN, RECORDED IN THESAXOTHURINGIAN FLYSCH, Geologische Rundschau, 86(3), 1997, pp. 599-611
Authors:
SOWADE O
WARNKE H
SCIGALLA P
SOWADE B
FRANKE W
MESSINGER D
GROSS J
Citation: O. Sowade et al., AVOIDANCE OF ALLOGENEIC BLOOD-TRANSFUSIONS BY TREATMENT WITH EPOETIN-BETA (RECOMBINANT-HUMAN-ERYTHROPOIETIN) IN PATIENTS UNDERGOING OPEN-HEART-SURGERY, Blood, 89(2), 1997, pp. 411-418
Authors:
MOCKS J
FRANKE W
EHMER B
SCIGALLA P
QUARDER O
Citation: J. Mocks et al., EPOETIN TREATMENT IN 3697 PATIENTS OF 22 CLINICAL-TRIALS - SAFETY DATABASE RESULTS AND LONG-TERM MORTALITY, Journal of the American Society of Nephrology, 7(9), 1996, pp. 746-746
Citation: W. Franke, ADVICE-GIVING INFORMATIVE TEXTS - REFLECT IONS ON THE LINGUISTIC DESCRIPTION OF ADVICE-GIVING CONTRIBUTIONS IN THE MASS-MEDIA, ZGL.Zeitschrift fur germanistische Linguistik, 24(3), 1996, pp. 249-272
Authors:
KASATKIN IA
GLIKIN AE
BRADACZEK H
FRANKE W
Citation: Ia. Kasatkin et al., KINETICS OF MIXED-CRYSTAL K-2(SO4, CRO4) GROWTH FROM AQUEOUS-SOLUTION, Crystal research and technology, 30(5), 1995, pp. 659-666
Authors:
BIESMA DH
MARX JJM
KRAAIJENHAGEN RJ
FRANKE W
MESSINGER D
VANDEWIEL A
Citation: Dh. Biesma et al., LOWER HOMOLOGOUS BLOOD REQUIREMENT IN AUTOLOGOUS BLOOD-DONORS AFTER TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN, Lancet, 344(8919), 1994, pp. 367-370